Tema Oncology ETF (NASDAQ:CANC) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its holdings in Tema Oncology ETF (NASDAQ:CANC) by 69.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 44,311 shares of the company’s stock after selling 98,880 shares during the quarter. Jane Street Group LLC owned about 2.55% of Tema Oncology ETF worth $1,259,000 as of its most recent filing with the SEC.

Separately, Thrivent Financial for Lutherans acquired a new position in Tema Oncology ETF in the 2nd quarter valued at $8,616,000.

Tema Oncology ETF Stock Down 0.8 %

Shares of NASDAQ:CANC opened at $24.67 on Friday. Tema Oncology ETF has a 52 week low of $24.00 and a 52 week high of $30.11. The company has a market cap of $42.93 million, a P/E ratio of 26.86 and a beta of 1.11. The company has a 50-day moving average price of $26.90 and a 200 day moving average price of $27.92.

Tema Oncology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were paid a dividend of $0.7283 per share. The ex-dividend date was Wednesday, December 11th.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.